Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Jack Jenkins, MS
Associate Director
Jazz Pharmaceuticals plc
Poster(s):
073: A Phase 1, Randomized, Placebo-Controlled, Double-Blind, 2-Period, Fixed-Sequence Study to Assess the Relative Bioavailability & Safety of Low-Sodium Oxybate Between Japanese & Non-Asian Participants
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
